#OrLocal
Retrospective EGPA study of mepolizumab Rx 45 pts Rx initially w/ 300 mg/4 weeks, 27% switched to 100 mg/4 wks after 26 mos & 50% maintained complete remission without GC. Other half had sinonasal Sxs Rx w/ increased MEP dose orlocal therapy. buff.ly/pRU4Uhv
April 24, 2025 at 5:01 AM
Retrospective EGPA study of mepolizumab Rx 45 pts Rx initially w/ 300 mg/4 weeks, 27% switched to 100 mg/4 wks after 26 mos & 50% maintained complete remission without GC. Other half had sinonasal Sxs Rx w/ increased MEP dose orlocal therapy. academic.oup.com/rheumatology...
academic.oup.com
April 21, 2025 at 10:12 PM
March 6, 2026 at 10:01 PM
February 18, 2026 at 4:05 AM